Literature DB >> 133002

Myocardial blood flow in congestive and hypertrophic cardiomyopathy: relationship to peak wall stress and mean velocity of circumferential fiber shortening.

M B Weiss, K Ellis, R R Sciacca, L L Johnson, D H Schmidt, P J Cannon.   

Abstract

Myocardial blood flow/unit mass (MBF) and the determinants of myocardial oxygen consumption were measured in seven control subjects (group I) and 15 patients (pts) with cardiomyopathy (CM), group II (group IIa-congestive CM: 10 pts; group IIb-hypertrophic CM: 5 pts). In group I left ventricular (LV) MBF was 64 +/- 8 (SD) ml/100g-min; it was significantly lower in IIa (45 +/- 15 ml/100g-min, P less than 0.01) and IIb (39 +/- 7 ml/100g-min, P less than 0.01). However, calculated total LV flow (LV mass X MBF) was increased in the two CM groups. In nine CM pts, LV MBF increased in response to atrial pacing from 41 +/- 7 to 63 +/- 13 ml/100g-min. In group IIa, calculated peak wall stress was normal (4.39 +/hortening (MVcf) was significantly reduced (0.53 +/- 0;18 vs 1.26 +/- 0.12 circum/sec, P less than 0.01). In IIb, MVcf was normal but peak stress was significantly reduced (2.80 +/- 0.75 vs 4.51 +/- 1.10 dynes/cm2 X 10(5), P less than 0.05). Multiple regression analysis based on all pts yielded, MBF - 16.9 MVcf + 9.30 Stress + 0.26 Heart Rate - 26.4 (r=0.79). The data indicate that MBF is reduced in CM patients and the regression analysis suggests that MBF in these 22 pts with normal coronary arteriograms was determined largely by heart rate, peak stress, and ventricular performance.

Entities:  

Mesh:

Year:  1976        PMID: 133002     DOI: 10.1161/01.cir.54.3.484

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

Review 1.  Myocardial perfusion and coronary microcirculation: from pathophysiology to clinical application.

Authors:  Antonio L'Abbate; Gianmario Sambuceti; Danilo Neglia
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

Review 2.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors:  Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

3.  Perfusion and mechanical analysis with technetium-99m 2-methoxy-isobutyl-isonitrile in a case of dilated cardiomyopathy.

Authors:  T Takeda; H Toyama; N Ishikawa; T Masuoka; R Ajisaka; K Iida; M Satoh; W Jin; T Saitou; T Yamanouchi
Journal:  Ann Nucl Med       Date:  1992-05       Impact factor: 2.668

4.  Mechanical pathophysiology of some heart diseases: a theoretical model study.

Authors:  R Beyar; S Sideman
Journal:  Med Biol Eng Comput       Date:  1990-05       Impact factor: 2.602

5.  Diastolic function in healthy humans: non-invasive assessment and the impact of acute and chronic exercise.

Authors:  Keith P George; Louise H Naylor; Greg P Whyte; Rob E Shave; David Oxborough; Daniel J Green
Journal:  Eur J Appl Physiol       Date:  2009-10-02       Impact factor: 3.078

Review 6.  The renin-angiotensin system and coronary vasomotion.

Authors:  G Ertl; K Hu; W R Bauer; B Bauer
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

7.  The dynamic twisting of the left ventricle: a computer study.

Authors:  R Beyar; S Sideman
Journal:  Ann Biomed Eng       Date:  1986       Impact factor: 3.934

Review 8.  Potential mechanisms of improvement after various treatments for hypertrophic obstructive cardiomyopathy.

Authors:  R D Leachman
Journal:  Tex Heart Inst J       Date:  1995

Review 9.  PET and SPECT in heart failure.

Authors:  Christoph Rischpler; Stephan Nekolla; Markus Schwaiger
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

10.  Myocardial oxygen consumption in aortic valve disease with and without left ventricular dysfunction.

Authors:  J Schwitter; F R Eberli; M Ritter; M Turina; H P Krayenbuehl
Journal:  Br Heart J       Date:  1992-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.